The present invention provides a compound represented by the formula
wherein each symbol is as defined in the specification, or a salt thereof. The compound of the present invention shows a strong IAP antagonistic activity.
[EN] NOVEL HETEROARYL IMIDAZOLES AND HETEROARYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS<br/>[FR] NOUVEAUX HÉTÉROARYL-IMIDAZOLES ET HÉTÉROARYL-TRIAZOLES À TITRE DE MODULATEURS DE GAMMA-SÉCRÉTASE
申请人:PFIZER
公开号:WO2011048525A1
公开(公告)日:2011-04-28
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I; (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
[EN] PYRIDAZINE DERIVATIVES FOR INHIBITING BETA AMYLOID PEPTIDE PRODUCTION<br/>[FR] DÉRIVÉS DE PYRIDAZINE POUR INHIBER LA PRODUCTION DE PEPTIDE BÉTA AMYLOÏDE
申请人:GLAXO GROUP LTD
公开号:WO2009050227A1
公开(公告)日:2009-04-23
The present invention relates to novel compounds that inhibit the production of β- amyloid peptide (1-42), processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.
NOVEL HETEROARYL IMIDAZOLES AND HETEROARYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS
申请人:Pfizer Inc
公开号:EP2491026A1
公开(公告)日:2012-08-29
[EN] ALANINE DERIVATIVES AS INHIBITORS OF APOPTOSIS PROTEINS<br/>[FR] DÉRIVÉS D'ALANINE COMME INHIBITEURS DE PROTÉINES D'APOPTOSE
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2011016576A1
公开(公告)日:2011-02-10
The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof. The compound of the present invention shows a strong IAP antagonistic activity.